Article
Elevated serum levels of Dupan-2 in pancreatic cancer patients negative for Lewis blood group phenotype.
British journal of cancer - 1 Nov 1991
Kawa S, Oguchi H, Kobayashi T, Tokoo M, Furuta S, Kanai M, Homma T
Abstract excerpt
CA19-9, a serum marker for pancreatic cancer, gives false-negative results in patients who are negative for the Lewis blood group phenotype. To determine whether other markers may compensate for this drawback, serum levels of CA50, Span-1, sialyl SSEA-1 and Dupan-2 were assayed and compared with...
Topics
- Adult
- Aged
- Antigens, Neoplasm
- Antigens, Tumor-Associated, Carbohydrate
- Enzyme-Linked Immunosorbent Assay
- False Negative Reactions
- Female
- Humans
- Lewis Blood Group Antigens
- Male
- Middle Aged
- Pancreatic Neoplasms
- Phenotype